NewswireToday - /newswire/ -
Barcelona, Spain, 2006/08/04 - Pharmapromo launches the most extensive reference website on the generic medication fluoxetine, aimed at both consumers and pharmaceutical and healthcare industry professionals - PharmaPromo.com
PharmaPromo, the owner of a major network of over 250 websites dedicated to generic medications, today announced the launch of the website fluoxetine. This unique medication website provides highly relevant and comprehensive information on the generic drug fluoxetine, more commonly known by its brand names Prozac®, Prozac Weekly® and Sarafem®.
Fluoxetine is used to treat depression and mental health conditions that currently affect over 15 million Americans. Over the last decade the global antidepressant medication market has seen an extraordinary growth and currently holds the position of the third leading drug class by prescription revenue. However, with only ten leading drugs on the market generating global sales of $14 billion in 2004 and nine out of these ten facing loss of patents between 2006 and 2011, the dynamics of this market are set to undergo considerable changes with very few blockbuster drugs entering the market. As generic competition intensifies, companies need to carefully re-examine their strategies if they wish to protect their market share.
Fluoxetine.com is set to become the leading reference point for both consumers and pharmaceutical industry professionals seeking reliable and accurate information in a market that is facing new challenges. It provides extensive product information and up-to-date resources, together with exclusive insider industry news on which companies and organizations are playing an important part in its research, development, production and promotion.
For consumers, this website provides access to relevant information and covers key topics regarding depression, obsessive-compulsive disorder, eating disorders such as bulimia nervosa, premenstrual dysphoric disorder and panic disorder. For them this medication provides a way of controlling their illness to prevent it from burdening their daily lives. Consumers are progressively being presented with a greater variety of medications that suit varying needs, both medically and economically. Fluoxetine.com is their source of accurate and detailed information about what is available on the market (either in its branded form or generic version).
From a pharmaceutical company or health organization stand point the website offers companies the opportunity to develop their corporate identity and extend their customer reach as it continues to attract an increasing amount of regular and highly targeted users. All visitors have the opportunity to take part in open discussion forums and share their own knowledge and experiences with other consumers. This hands-on approach by regular patients and pharmacists who have had experience using fluoxetine will create an expansive community and interactive meeting point.
PharmaPromo is one of several online business divisions provided by the Anakena Group, a European company located in Barcelona, Spain. Founded in April 1999, the company is dedicated to developing innovative Internet strategies for specific niches including the pharmaceutical market. It focuses on providing a unique service for patients, and offer leading pharmaceutical companies, manufacturers, PBMs and healthcare professionals the most competitive solutions for strengthening the reach and frequency of their corporate message, as well as securing their company’s online presence via a highly-targeted advertising platform. The completion of fluoxetine.com adds further depth to the PharmaPromo project - covering the top-selling worldwide drugs and principal therapeutic areas – and predicts the completion of its redevelopment project by September 2006.
Editorial note: Prozac®, Prozac Weekly® and Sarafem® are registered trademarks of Eli Lilly and Company.
Richard Cottrell, B2B Development Manager
T: +34 93 183 3330 / El: richard[.]pharmapromo.com / Skype: pharmapromo